Hunan Nucien Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Hunan Nucien Pharmaceutical has a total shareholder equity of CN¥1.2B and total debt of CN¥65.1M, which brings its debt-to-equity ratio to 5.4%. Its total assets and total liabilities are CN¥1.4B and CN¥158.9M respectively.
Key information
5.4%
Debt to equity ratio
CN¥65.05m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥389.08m |
| Equity | CN¥1.21b |
| Total liabilities | CN¥158.90m |
| Total assets | CN¥1.37b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688189's short term assets (CN¥911.2M) exceed its short term liabilities (CN¥153.8M).
Long Term Liabilities: 688189's short term assets (CN¥911.2M) exceed its long term liabilities (CN¥5.1M).
Debt to Equity History and Analysis
Debt Level: 688189 has more cash than its total debt.
Reducing Debt: 688189's debt to equity ratio has reduced from 99.1% to 5.4% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 688189 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 688189 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 31.4% per year.